Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery

28. oktober 2026 oppdatert av: Biyu Shen, Shanghai Jiao Tong University School of Medicine

Effects of Starry-Sky Projection and Maternal Voice on Postoperative Sleep in Children Undergoing Cardiac Surgery: A 2 × 2 Factorial Randomized Controlled Trial

The goal of this clinical trial is to determine whether a starry-sky projection affects sleep during the early period after cardiac surgery in young children. The main question it aims to answer is:

• Does a starry-sky projection improve how well children sleep during the first three nights after surgery compared with routine nighttime lighting? The study will also explore whether sleep outcomes differ between children who listen to their mother's recorded voice and those who listen to an unfamiliar woman's recorded voice, and whether the effect of the starry-sky projection differs depending on the type of voice.

Children aged 6 months to 6 years will be randomly assigned to one of four combinations of visual and sound conditions. They will:

  • Receive either a starry-sky projection or routine nighttime lighting
  • Listen to either their mother's recorded voice or an unfamiliar woman's recorded voice
  • Have their sleep monitored during the first three nights after surgery using a contactless device placed under the pillow that does not require sensors attached to the child.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

172

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200127
        • Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

6 måneder til 6 år (Barn)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • A confirmed diagnosis of congenital heart disease.
  • Age between 6 months and 6 years.
  • Scheduled to undergo their first elective open-heart surgery.
  • An anticipated postoperative stay in the cardiac intensive care unit (CICU) of at least 48 hours.
  • Written informed consent provided by a parent or legal guardian.

Exclusion Criteria:

  • Epilepsy or another severe neurological disorder.
  • A severe psychiatric disorder.
  • Hearing impairment that interferes with the perception of auditory stimuli.
  • Visual impairment that interferes with the perception of visual stimuli.
  • Malformations of other organs or pre-existing severe comorbidities.
  • A history of chronic pain.
  • A previously diagnosed sleep disorder.
  • Endotracheal tube could not be successfully removed before 7 p.m. on the day of surgery.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Faktoriell oppgave
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Starry-Sky Projection + Maternal Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Eksperimentell: Starry-Sky Projection + Unfamiliar Female Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Aktiv komparator: Conventional Lighting + Maternal Voice

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Aktiv komparator: Conventional Lighting + Unfamiliar Female Voice

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Sleep Efficiency
Tidsramme: Postoperative nights 0, 1, and 2

Sleep efficiency is defined as the percentage of total sleep time (TST) relative to time in bed (TIB) during the sleep-related nocturnal interval. TIB refers to the interval from the start of an attempt to sleep until the end of the nocturnal sleep opportunity and includes sleep onset latency and intervening wakefulness. Sleep efficiency will be assessed using a contactless ballistocardiography (BCG)-based sleep monitoring mat during postoperative nights 0-2. The mean sleep efficiency across the three postoperative nights will be used as the primary outcome measure. Higher values indicate better sleep efficiency.

Postoperative nights 0, 1, and 2

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Total Sleep Time
Tidsramme: Postoperative nights 0, 1, and 2

Total sleep time during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep-Onset Latency
Tidsramme: Postoperative nights 0, 1, and 2

Time from the beginning of the nocturnal sleep monitoring period to sleep onset, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Wake After Sleep Onset
Tidsramme: Postoperative nights 0, 1, and 2

Total duration of wakefulness occurring after sleep onset during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep Fragmentation Index
Tidsramme: Postoperative nights 0, 1, and 2

Sleep fragmentation index derived from the contactless sleep monitoring mat, reflecting the degree of sleep disruption during the nocturnal monitoring period.

Postoperative nights 0, 1, and 2
Sleep-Stage Distribution
Tidsramme: Postoperative nights 0, 1, and 2

Estimated distribution of sleep stages during the nocturnal monitoring period, expressed as the proportion of total sleep time and measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Incidence of Postoperative Delirium
Tidsramme: Postoperative night 0 through postoperative day 2

Postoperative delirium will be assessed using the Cornell Assessment of Pediatric Delirium (CAPD). A total CAPD score ≥9 will indicate a positive delirium screen. Assessments will be performed every 12 hours.

Postoperative night 0 through postoperative day 2
Richmond Agitation-Sedation Scale Score
Tidsramme: Postoperative night 0 through postoperative day 2

Sedation and agitation will be assessed using the Richmond Agitation-Sedation Scale (RASS). Scores range from -5 to +4, with lower scores indicating deeper sedation and higher scores indicating greater agitation. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Pain Score
Tidsramme: Postoperative night 0 through postoperative day 2

Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale. Scores range from 0 to 10, with higher scores indicating greater pain severity. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Postoperative Sedative Exposure
Tidsramme: Postoperative day 0 through postoperative day 2

Administration of dexmedetomidine and other sedative medications will be recorded to characterize postoperative sedative exposure.

Postoperative day 0 through postoperative day 2
Postoperative Analgesic Exposure
Tidsramme: Postoperative day 0 through postoperative day 2

Administration of sufentanil and other analgesic medications will be recorded to characterize postoperative analgesic exposure.

Postoperative day 0 through postoperative day 2
Postoperative Vasoactive Medication Exposure
Tidsramme: Postoperative day 0 through postoperative day 2

Administration of dopamine and other vasoactive medications will be recorded to characterize postoperative vasoactive medication exposure.

Postoperative day 0 through postoperative day 2
Heart Rate Variability
Tidsramme: Postoperative nights 0, 1, and 2

Heart rate variability will be continuously measured using the 5S Sleep Tracking Mat as an objective indicator of autonomic regulation.

Postoperative nights 0, 1, and 2
CICU Length of Stay
Tidsramme: Measured in days admitted to the CICU, an average of 2 days

Cardiac intensive care unit (CICU) length of stay will be calculated from postoperative CICU admission to CICU discharge.

Measured in days admitted to the CICU, an average of 2 days
Total Hospital Length of Stay
Tidsramme: Measured in days admitted to the hospital, an average of 10 days.

Total hospital length of stay will be calculated as the number of days from hospital admission to hospital discharge.

Measured in days admitted to the hospital, an average of 10 days.
Parental satisfaction
Tidsramme: On the day of discharge, an average of 10 days

Parental satisfaction with the child's overall hospital care will be assessed using a 100-mm visual analogue scale (VAS), ranging from 0 mm ("very dissatisfied") to 100 mm ("very satisfied"). Higher scores indicate greater satisfaction.

On the day of discharge, an average of 10 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

31. mars 2027

Studiet fullført (Antatt)

31. mars 2027

Datoer for studieregistrering

Først innsendt

22. september 2026

Først innsendt som oppfylte QC-kriteriene

26. september 2026

Først lagt ut (Faktiske)

2. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

30. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

28. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere